SequelSEC

Vivani Medical, Inc. VANI

Electromedical & Electrotherapeutic Apparatus · CIK 0001266806 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2025-12-31
Operating income
-$27.56M
Fiscal year ended 2025-12-31
Free cash flow
-$25.49M
Fiscal year ended 2025-12-31

Vivani Medical, Inc. (VANI) reported revenue of $0 and net income of -$26.61M for the fiscal year ended 2025-12-31. This page shows 8 annual periods of income statement, balance sheet and cash flow figures normalized from Vivani Medical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.

Income

Vivani Medical, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$0$0$3.38M$6.90M$7.96M$3.98M$8.90M$3.40M
Cost of revenueUnavailableUnavailable$2.15M$4.89M$5.12M$10.08M$5.29M$3.56M
Gross profitUnavailableUnavailable$1.23M$2.01M$2.85M-$6.09M$3.66M-$160.00K
Operating income-$27.56M-$24.68M-$33.95M-$35.18M-$28.61M-$33.21M-$20.05M-$21.23M
Net income-$26.61M-$23.49M-$33.59M-$35.09M-$28.52M-$33.18M-$20.02M-$35.20M
Research & development$18.13M$15.74M$13.14M$10.00M$7.89M$5.35M$3.04M$5.04M
Weighted-average diluted sharesshares 62.39Mshares 54.98MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax income-$26.61M-$23.49MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailable$2.00K$0$0UnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.43$-0.43UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailable$15.33M$22.03M$20.50M$19.07M$17.16M$13.41M
General & administrative$9.43M$8.93M$9.23M$10.69M$10.93M$10.08M$8.22M$6.56M
Selling & marketingUnavailableUnavailable$6.10M$11.34M$9.57M$8.99M$8.94M$6.84M

Balance

Vivani Medical, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Cash & equivalents$16.23M$18.35M$11.33M$4.47M$7.84M$10.88M$15.96M$619
Total assets$39.39M$41.56M$16.60M$10.68M$14.50M$16.81M$28.24M$43.07M
Current assets$17.90M$20.44M$13.11M$9.62M$13.16M$15.28M$26.76M$41.98M
Total liabilities$23.66M$23.95M$9.32M$7.60MUnavailableUnavailableUnavailableUnavailable
Current liabilities$6.60M$5.99M$6.96M$7.60M$6.62M$5.66M$7.98M$8.45M
Total equity incl. NCI$15.73M$17.61M$7.28M$3.08M$7.88M$11.15M$20.26M$34.62M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailable$1.03M$3.25M$2.70M$3.42M$8.21M$5.72M
Accounts receivableUnavailableUnavailable$455.00K$504.00K$1.83M$274.00K$1.50M$708.00K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$1.03M$817.00K$1.09M$1.30M$752.00K$1.16M$710.00K$513.00K

Cash flow

Vivani Medical, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating cash flow-$24.32M-$20.79M-$27.63M-$29.81M-$23.95M-$25.07M-$20.55MUnavailable
Capital expenditures$1.17M$556.00K$493.00K$163.00K$265.00K$490.00K$762.00K$560.00K
Investing cash flow-$1.17M-$556.00K-$493.00K-$163.00K-$265.00K-$490.00K$17.52M-$25.95M
Financing cash flow$23.27M$19.05M$34.99M$26.60M$21.17M$20.45M$2.76M$43.80M
Net change in cash-$2.12M-$2.30M$6.86M-$3.37M-$3.04M-$5.08M-$380.00K$557.00K
Stock-based compensation$1.48M$1.61M$2.92M$3.59M$3.78M$3.37M$2.69M$1.48M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$424.00K$400.00K$397.00K$435.00K$457.00K$432.00K$335.00K$279.00K

Derived

Vivani Medical, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Free cash flow-$25.49M-$21.34M-$28.12M-$29.97M-$24.21M-$25.56M-$21.31MUnavailable
Gross marginUnavailableUnavailable36.3%Unavailable35.7%-152.8%Unavailable-4.7%
Operating marginUnavailableUnavailable-1004.9%Unavailable-359.2%-833.4%Unavailable-624.5%
FCF marginUnavailableUnavailable-832.3%Unavailable-304.0%-641.4%UnavailableUnavailable
SBC / revenueUnavailableUnavailable86.6%Unavailable47.5%84.5%Unavailable43.4%
Current ratio2.71x3.41x1.88x1.27x1.99x2.70x3.35x4.97x
Revenue YoY growthUnavailableUnavailable-51.0%-13.4%99.8%-55.2%161.8%Unavailable
Net marginUnavailableUnavailable-994.1%Unavailable-358.1%-832.6%Unavailable-1035.3%
R&D / revenueUnavailableUnavailable389.0%Unavailable99.1%134.2%Unavailable148.3%
CapEx / revenueUnavailableUnavailable14.6%Unavailable3.3%12.3%Unavailable16.5%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VANI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-26View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

ADMT AXGN BLFS CBLL CNMD CV ECOR ELMD ESMC FOCL GTHP HCIL

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.